Benign neoplasm: Ureter

CD2_BENIGN_URETER

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D30.2& Hospital discharge: ICD-9 — 2232 Hospital discharge: ICD-8 — 2232 Cause of death: ICD-10 — D30.2& Cause of death: ICD-9 — 2232 Cause of death: ICD-8 — 2232 2 out of 7 registries used, show all original rules.	24
4. Check minimum number of events None	24
5. Include endpoints None	24
6. Filter based on genotype QC (FinnGen only)	24

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D30
Name in latin: Neoplasma benignum ureteris

NAME	CD2_BENIGN_URETER
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D302
HD_ICD_9	2232
HD_ICD_8	2232
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D302
COD_ICD_9	2232
COD_ICD_8	2232
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Ureter based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Ureter

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	196	100	95
Only index persons	141	73	68
Unadjusted period prevalence (%)
Whole population	0.00	0.00	0.00
Only index persons	0.00	0.00	0.00
Median age at first event (years)
Whole population	62.14	59.60	64.89
Only index persons	58.62	56.12	61.30

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	24	14	10
Unadjusted period prevalence (%)	0.00	0.00	0.00
Median age at first event (years)	64.27	66.36	61.35

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

7.52

2.49

1.4

2.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3.38

2.12

2.2

2.6

83.3

77.4

nmol/l

0.47

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4.08

1.88

1.7

2.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3.04

1.80

2.4

2.1

98.4

92.8

pmol/l

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3.85

1.79

1.7

2.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.98

1.40

1.0

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2.85

1.34

1.0

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.57

1.17

1.6

2.8

—

(3018095) Leukocytes [#/volume] in Urine

2.28

1.07

6.4

4.5

7.5

30.3

e6/l

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

2.24

1.03

5.6

3.5

—

(3002582) Erythrocytes [#/volume] in Urine

2.20

0.99

4.8

3.5

13.5

863.5

e6/l

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

118

2.06

0.87

3.1

12.7

4.1

4.6

e9/l

—

107

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.99

0.78

1.3

2.6

—

(40768797) Stomach Pathology biopsy report

1.91

0.68

1.2

1.3

—

(3018418) pH of Serum or Plasma

1.84

0.66

8.3

6.2

—

7.4

—

(3019060) Gas panel - Arterial blood

0.00

0.63

0.0

3.3

—

(40761536) Microorganisms panel - Urine sediment

0.00

0.63

0.0

4.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

0.00

0.61

0.0

4.8

—

(3033658) Prothrombin time (PT) actual/Normal

1.78

0.56

5.7

3.2

77.1

91.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

139

1.76

0.56

5.6

5.8

—

32.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1.67

0.48

1.8

2.3

—

(3019225) pH of Specimen

1.84

0.47

6.0

5.1

—

(42870588) Differential panel, method unspecified - Blood

1.58

0.46

4.2

5.7

—

(36304419) Bacteria [Presence] in Urine

1.58

0.46

5.6

3.1

—

(3044640) Blood type and Crossmatch panel - Blood

1.55

0.46

1.6

2.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1.71

0.45

4.6

2.3

20.0

19.6

—

(3025941) Bacteria identified in Stool by Culture

0.00

0.43

0.0

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.00

0.41

0.0

1.3

—

(40768804) Tissue Pathology biopsy report

1.51

0.33

1.4

1.9

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1.40

0.31

2.3

290.4

136.0

u/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

0.70

0.29

1.9

4.1

—

(3021589) Normoblasts [#/volume] in Blood

1.44

0.27

3.6

12.5

0.0

e9/l

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

202

0.72

0.25

23.7

22.3

107.8

79.9

umol/l

0.75

202

(3015736) pH of Urine

1.40

0.24

1.9

5.0

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

0.00

0.22

0.0

4.4

—

45.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.22

0.0

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

0.00

0.22

0.0

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.22

0.0

2.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.22

0.0

2.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

0.00

0.22

0.0

4.4

—

127.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.22

0.0

1.9

—

(3018405) Lactate [Moles/volume] in Arterial blood

0.00

0.22

0.0

2.1

—

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

0.00

0.21

0.0

4.1

—

57.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

0.00

0.21

0.0

2.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

0.67

0.20

2.0

4.8

—

(3026008) Bacteria identified in Urine by Culture

1.35

0.19

3.2

3.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

0.78

0.18

2.0

5.2

—

(3044889) 12 lead EKG panel

138

1.23

0.17

2.9

4.4

—

(40761511) CBC panel - Blood by Automated count

198

0.81

0.11

13.3

17.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1.24

0.11

1.2

—

0.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1.17

0.11

1.8

4.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1.20

0.10

2.0

2.5

5.0

3.4

mg/l

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

118

1.22

0.10

4.2

4.3

7.1

6.8

mmol/l

0.17

109

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

0.78

0.09

5.3

5.2

3.8

2.0

ug/l

—

(3013512) EKG study

0.86

0.08

3.9

4.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

131

0.83

0.08

2.9

6.9

11.1

10.8

umol/l

0.07

125

(3009261) Glucose [Presence] in Urine by Test strip

109

0.86

0.05

2.0

5.1

—

0.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

106

0.90

0.01

3.3

7.4

—

0.0

—

(3035350) Ketones [Presence] in Urine by Test strip

106

1.07

0.00

2.3

5.1

—

0.0

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

2.2

—

3.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(4094501)

0.00

0.0

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

2.2

—

107.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

4.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

2.2

—

(3029937) Albumin [Presence] in Urine by Test strip

0.87

0.00

1.4

4.8

—

0.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.00

0.0

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.0

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

153

0.95

0.00

25.1

17.4

39.5

40.7

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

148

1.04

0.00

3.9

5.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.0

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.0

5.6

—

8.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.0

5.6

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.0

2.9

—

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.0

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

0.0

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

0.00

0.0

4.1

—

0.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

0.00

0.0

1.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.0

5.6

—

4.9

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(3023368) Bacteria identified in Blood by Culture

1.04

0.00

4.7

4.8

—

(3020891) Body temperature

0.00

0.0

4.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.0

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.0

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

0.00

0.0

4.1

—

0.8

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

3.8

—

32.9

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

187

1.08

0.00

20.6

18.3

68.9

71.7

ml/min/173m2

0.17

153

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.00

0.0

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.0

3.3

—

116.7

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

7.1

—

(40758558) Short blood count panel - Blood

1.05

0.00

1.7

9.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.0

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.0

2.9

—

5.7

—

(3021901) Oxygen saturation in Capillary blood

0.00

0.0

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

0.00

0.0

33.6

—

6.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

13.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.00

0.0

1.0

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.0

6.2

—

(3008898) HLA-B27 [Presence]

0.00

0.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_URETER and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_URETER.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_URETER – Benign neoplasm: Ureter

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Ureter

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints